首页 > 最新文献

Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih最新文献

英文 中文
Effects of alcohol intake on penile structure and function in rats. 酒精摄入对大鼠阴茎结构和功能的影响。
Xiu-guo Gan, Xue-ming Shi, Rui Liu, Rui-hua An, Yong-quan Wang

Objective: To investigate the effects of alcohol intake on penile structure and function in rats.

Methods: Thirty adult male Wistar rats were randomly divided into two groups: control group and alcohol intake group. They were administered with 2 mL of normal saline and 40% alcohol solution respectively through gastric tubes every day. Three months later, the animal model of alcohol intake was evaluated by modified Nayagida's method, and the effects of alcohol on the rats were studied by sexual behavior, the number of apomorphine-induced penile erection, level of testosterone in the sera, and the content of penile smooth muscle.

Results: The scores of animal model of alcohol intake evaluated by Nayagida's method were 0.66 +/- 2.05 in the control group and 9.26 +/- 5.50 in the alcohol intake group (P < 0.05), which indicated that an animal model of alcohol intake was successfully established. Sexual behavior, the number of apomorphine-induced penile erection, testosterone level in the sera, and the content of penile smooth muscle of the alcohol intake group were all statistically different as compared with the control group (P < 0.05).

Conclusion: Alcohol intake induces sexual dysfunction in rats, which may be due to the decline of testosterone level in the sera and decline of penile smooth muscle.

目的:探讨酒精摄入对大鼠阴茎结构和功能的影响。方法:30只成年雄性Wistar大鼠随机分为对照组和酒精摄入组。每日经胃管分别给予生理盐水2ml和40%酒精溶液。3个月后,采用改良的Nayagida法对酒精摄入动物模型进行评估,并通过性行为、阿波吗啡诱导的阴茎勃起次数、血清睾酮水平和阴茎平滑肌含量研究酒精对大鼠的影响。结果:用Nayagida法评价酒精摄入动物模型,对照组得分为0.66 +/- 2.05,酒精摄入组得分为9.26 +/- 5.50 (P < 0.05),成功建立了酒精摄入动物模型。酒精摄入组的性行为、阿帕吗啡致阴茎勃起次数、血清睾酮水平、阴茎平滑肌含量与对照组比较,差异均有统计学意义(P < 0.05)。结论:酒精摄入引起大鼠性功能障碍,可能与血清睾酮水平下降和阴茎平滑肌萎缩有关。
{"title":"Effects of alcohol intake on penile structure and function in rats.","authors":"Xiu-guo Gan,&nbsp;Xue-ming Shi,&nbsp;Rui Liu,&nbsp;Rui-hua An,&nbsp;Yong-quan Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the effects of alcohol intake on penile structure and function in rats.</p><p><strong>Methods: </strong>Thirty adult male Wistar rats were randomly divided into two groups: control group and alcohol intake group. They were administered with 2 mL of normal saline and 40% alcohol solution respectively through gastric tubes every day. Three months later, the animal model of alcohol intake was evaluated by modified Nayagida's method, and the effects of alcohol on the rats were studied by sexual behavior, the number of apomorphine-induced penile erection, level of testosterone in the sera, and the content of penile smooth muscle.</p><p><strong>Results: </strong>The scores of animal model of alcohol intake evaluated by Nayagida's method were 0.66 +/- 2.05 in the control group and 9.26 +/- 5.50 in the alcohol intake group (P < 0.05), which indicated that an animal model of alcohol intake was successfully established. Sexual behavior, the number of apomorphine-induced penile erection, testosterone level in the sera, and the content of penile smooth muscle of the alcohol intake group were all statistically different as compared with the control group (P < 0.05).</p><p><strong>Conclusion: </strong>Alcohol intake induces sexual dysfunction in rats, which may be due to the decline of testosterone level in the sera and decline of penile smooth muscle.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"192-5"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27071876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impaired erythropoietin response to anemia in patients with lymphocytic malignancies. 淋巴细胞恶性肿瘤患者贫血时促红细胞生成素反应受损。
Bing Han, Yuan-kai Shi, Jun Zhu, Xiao-hui He, Ning-jing Lin, Shu-lan Li, Ti Shen
{"title":"Impaired erythropoietin response to anemia in patients with lymphocytic malignancies.","authors":"Bing Han,&nbsp;Yuan-kai Shi,&nbsp;Jun Zhu,&nbsp;Xiao-hui He,&nbsp;Ning-jing Lin,&nbsp;Shu-lan Li,&nbsp;Ti Shen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"203-4"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27071879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and management of isolated pancreatic tuberculosis: experience of 13 cases. 孤立性胰腺结核的诊断与治疗:附13例体会。
Chang-qing Yan, Jun-chao Guo, Yu-pei Zhao

Objective: To analyze the diagnosis and treatment of pancreatic tuberculosis.

Methods: Retrospectively reviewed and summarized 13 pancreatic tuberculosis patients' clinical information, presentation, diagnostic methods, therapeutic approaches, and prognosis from 1958 to 2004 at Peking Union Medical College Hospital.

Results: All cases presented a wide series of symptoms, including fever in 6 cases, upper abdominal tenderness in 13, epigastric mass in 4, obstructive jaundice in 3, night sweat in 4, weight loss in 7, hypersplenotrophy and hypersplenism in 1, and being complicated with tuberculosis of other organs in 3. One case was diagnosed by clinical symptoms and biopsy of lymph node, and only received anti-tubercular treatment Others were diagnosed by intra-operative biopsy and anti-tubercular treatment, and got well without recurrent tuberculosis in pancreas and other organs during 6 months to 2 years of follow-up. The non-operative case presented extrahepatic portal hypertension.

Conclusions: Pancreatic tuberculosis may be considered in the patients with fever, abdominal tenderness, weight loss, and imaging evidence of regional pancreatic lesion. Efficacy of anti-tubercular agents and laparotomy for pancreatic tuberculosis is evident.

目的:探讨胰腺结核的诊断和治疗方法。方法:回顾性分析北京协和医院1958 ~ 2004年收治的13例胰腺结核患者的临床资料、临床表现、诊断方法、治疗方法及预后。结果:所有病例均表现出广泛的症状,发热6例,上腹部压痛13例,上腹部肿块4例,梗阻性黄疸3例,盗汗4例,体重减轻7例,脾肥厚、脾功能亢进1例,合并其他脏器结核3例。1例经临床症状及淋巴结活检确诊,仅接受抗结核治疗;其余经术中活检及抗结核治疗确诊,随访6个月~ 2年,无胰腺等脏器结核复发。非手术病例表现为肝外门静脉高压症。结论:有发热、腹部压痛、体重减轻和胰腺局部病变影像学证据的患者可考虑胰腺结核。抗结核药物及剖腹手术治疗胰结核疗效明显。
{"title":"Diagnosis and management of isolated pancreatic tuberculosis: experience of 13 cases.","authors":"Chang-qing Yan,&nbsp;Jun-chao Guo,&nbsp;Yu-pei Zhao","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the diagnosis and treatment of pancreatic tuberculosis.</p><p><strong>Methods: </strong>Retrospectively reviewed and summarized 13 pancreatic tuberculosis patients' clinical information, presentation, diagnostic methods, therapeutic approaches, and prognosis from 1958 to 2004 at Peking Union Medical College Hospital.</p><p><strong>Results: </strong>All cases presented a wide series of symptoms, including fever in 6 cases, upper abdominal tenderness in 13, epigastric mass in 4, obstructive jaundice in 3, night sweat in 4, weight loss in 7, hypersplenotrophy and hypersplenism in 1, and being complicated with tuberculosis of other organs in 3. One case was diagnosed by clinical symptoms and biopsy of lymph node, and only received anti-tubercular treatment Others were diagnosed by intra-operative biopsy and anti-tubercular treatment, and got well without recurrent tuberculosis in pancreas and other organs during 6 months to 2 years of follow-up. The non-operative case presented extrahepatic portal hypertension.</p><p><strong>Conclusions: </strong>Pancreatic tuberculosis may be considered in the patients with fever, abdominal tenderness, weight loss, and imaging evidence of regional pancreatic lesion. Efficacy of anti-tubercular agents and laparotomy for pancreatic tuberculosis is evident.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"152-5"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27074830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical management of pseudoaneurysm complicating arteriovenous fistula for hemodialysis. 血液透析假性动脉瘤并发动静脉瘘的手术治疗。
Yue-hong Zheng, Chang-wei Liu, Heng Guan, Hong-bing Gan, Ui Kuok, Chao-liang Li, Jian Zhang, Dias Che Sok In, Furtado Rui

Objective: To report surgical experience in pseudoaneurysm (PA) repair of arteriovenous fistula (AVF) for renal hemodialysis.

Methods: Twenty patients undergoing PA repair of AVF for renal hemodialysis were treated in Central Hospital Conde S. Januario of Macao. Sixteen patients had PAs of AVF in upper extremities, 4 in lower extremities. All patients were treated with surgical therapy.

Results: All operations were finished without death. One patient suffered from acute thrombosis, recovered without any complication through instant thrombectomy. One patient with postoperative incision bleeding recovered after low molecular weight heparin was ceased. And one AVF could not be mature six weeks later, was recovered after ligation of branch vein. And one patient died due to recurrent cerebral infarction.

Conclusion: Surgical repair is the best choice for PA of AVF for renal hemodialysis.

目的:报道肾血液透析假性动脉瘤(PA)修复动静脉瘘(AVF)的手术经验。方法:对20例在澳门康泰中心医院行肾血液透析AVF PA修复术的患者进行治疗。上肢AVF PAs 16例,下肢pa 4例。所有患者均行手术治疗。结果:全部手术完成,无死亡病例。1例急性血栓形成,经立即取栓恢复,无并发症。1例术后切口出血患者停用低分子肝素后恢复。1只AVF 6周后仍未成熟,经支静脉结扎后恢复。还有一名患者死于复发性脑梗死。结论:手术修复是肾血液透析AVF PA的最佳选择。
{"title":"Surgical management of pseudoaneurysm complicating arteriovenous fistula for hemodialysis.","authors":"Yue-hong Zheng,&nbsp;Chang-wei Liu,&nbsp;Heng Guan,&nbsp;Hong-bing Gan,&nbsp;Ui Kuok,&nbsp;Chao-liang Li,&nbsp;Jian Zhang,&nbsp;Dias Che Sok In,&nbsp;Furtado Rui","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To report surgical experience in pseudoaneurysm (PA) repair of arteriovenous fistula (AVF) for renal hemodialysis.</p><p><strong>Methods: </strong>Twenty patients undergoing PA repair of AVF for renal hemodialysis were treated in Central Hospital Conde S. Januario of Macao. Sixteen patients had PAs of AVF in upper extremities, 4 in lower extremities. All patients were treated with surgical therapy.</p><p><strong>Results: </strong>All operations were finished without death. One patient suffered from acute thrombosis, recovered without any complication through instant thrombectomy. One patient with postoperative incision bleeding recovered after low molecular weight heparin was ceased. And one AVF could not be mature six weeks later, was recovered after ligation of branch vein. And one patient died due to recurrent cerebral infarction.</p><p><strong>Conclusion: </strong>Surgical repair is the best choice for PA of AVF for renal hemodialysis.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"196-8"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27071877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of B lymphocyte and its subpopulations in pathogenesis of immunorelated pancytopenia. B淋巴细胞及其亚群在免疫相关性全血细胞减少发病机制中的作用。
Rong Fu, Zong-hong Shao, Hong Liu, Yu-hong Wu, Hua-quan Wang, Li-min Xing

Objective: To measure the quantities and apoptosis-related protein levels of B lymphocyte in the patients with immunorelated pancytopenia (IRP) and explore the action of B lymphocyte in the pathogenic mechanism of IRP.

Methods: Quantities of whole B lymphocytes and CD5+ B lymphocytes as well as the expressions of Fas and Bcl-2 in B lymphocytes in 35 patients with untreated IRP, 15 IRP patients in complete remission (CR), and 10 normal controls were assayed by flow cytometry.

Results: The percentages of B lymphocyte and CD5+ B lymphocyte were significantly higher in untreated IRP patients than in CR IRP patients and normal controls (P < 0.05), and there was no significant difference between the latter two groups (P > 0.05). There was no significant difference of Fas expression in B lymphocyte among three groups (P > 0.05). The expression of Bcl-2 in B lymphocyte was significantly higher in untreated patients than in CR patients or normal controls (P < 0.01), and significantly higher in CR patients than in normal controls (P < 0.01). The apoptosis-related index was significantly lower in untreated patients than in CR patients or normal controls (P < 0.05), and significantly lower in CR patients than in normal controls (P < 0.05). The percentage of B lymphocyte was positively correlated with post-treated response time (r = 0.53, P < 0.01).

Conclusion: The production of auto-antibodies in IRP patients probably has some relationship with the abnormal quantities of B lymphocyte and its subpopulations as well as with the inhibition of B lymphocyte apoptosis.

目的:测定免疫相关性全细胞减少症(IRP)患者B淋巴细胞数量及凋亡相关蛋白水平,探讨B淋巴细胞在IRP发病机制中的作用。方法:采用流式细胞术检测35例未治疗的IRP患者、15例完全缓解(CR)的IRP患者和10例正常对照患者的全B淋巴细胞、CD5+ B淋巴细胞数量及B淋巴细胞Fas和Bcl-2的表达。结果:未经治疗的IRP患者B淋巴细胞和CD5+ B淋巴细胞百分比明显高于CR组和正常对照组(P < 0.05),后两组比较差异无统计学意义(P > 0.05)。各组B淋巴细胞Fas表达量差异无统计学意义(P > 0.05)。未治疗组患者B淋巴细胞Bcl-2表达明显高于CR组和正常对照组(P < 0.01), CR组患者B淋巴细胞Bcl-2表达明显高于正常对照组(P < 0.01)。未治疗组细胞凋亡相关指数明显低于CR组和正常对照组(P < 0.05), CR组明显低于正常对照组(P < 0.05)。B淋巴细胞百分比与治疗后反应时间呈正相关(r = 0.53, P < 0.01)。结论:IRP患者自身抗体的产生可能与B淋巴细胞及其亚群数量异常以及B淋巴细胞凋亡受到抑制有关。
{"title":"Role of B lymphocyte and its subpopulations in pathogenesis of immunorelated pancytopenia.","authors":"Rong Fu,&nbsp;Zong-hong Shao,&nbsp;Hong Liu,&nbsp;Yu-hong Wu,&nbsp;Hua-quan Wang,&nbsp;Li-min Xing","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To measure the quantities and apoptosis-related protein levels of B lymphocyte in the patients with immunorelated pancytopenia (IRP) and explore the action of B lymphocyte in the pathogenic mechanism of IRP.</p><p><strong>Methods: </strong>Quantities of whole B lymphocytes and CD5+ B lymphocytes as well as the expressions of Fas and Bcl-2 in B lymphocytes in 35 patients with untreated IRP, 15 IRP patients in complete remission (CR), and 10 normal controls were assayed by flow cytometry.</p><p><strong>Results: </strong>The percentages of B lymphocyte and CD5+ B lymphocyte were significantly higher in untreated IRP patients than in CR IRP patients and normal controls (P < 0.05), and there was no significant difference between the latter two groups (P > 0.05). There was no significant difference of Fas expression in B lymphocyte among three groups (P > 0.05). The expression of Bcl-2 in B lymphocyte was significantly higher in untreated patients than in CR patients or normal controls (P < 0.01), and significantly higher in CR patients than in normal controls (P < 0.01). The apoptosis-related index was significantly lower in untreated patients than in CR patients or normal controls (P < 0.05), and significantly lower in CR patients than in normal controls (P < 0.05). The percentage of B lymphocyte was positively correlated with post-treated response time (r = 0.53, P < 0.01).</p><p><strong>Conclusion: </strong>The production of auto-antibodies in IRP patients probably has some relationship with the abnormal quantities of B lymphocyte and its subpopulations as well as with the inhibition of B lymphocyte apoptosis.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"199-202"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27071878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Video-assisted thoracoscopic correction and fusion of scoliosis. 视频胸腔镜下脊柱侧凸矫正与融合。
Bin Yu, Jian-guo Zhang, Gui-xing Qiu, Yi-peng Wang, Xin-yu Yang

Objective: To evaluate the operative technique and preliminary results of video-assisted thoracoscopic anterior correction and fusion of scoliosis.

Methods: Eleven cases underwent thoracoscopic anterior correction and fusion of scoliosis from March 2003 to April 2005 in our hospital were reviewed. They were all females with an average age of 13.1 years old. Of which, 9 cases were idiopathic scoliosis, 1 case was congenital scoliosis, and 1 case was Marfan syndrome scoliosis. The coronal Cobb angle and apical vertebral translation before and after surgery as well as at final follow-up were measured. The operation time, blood loss during operation, and peri-operative complications were recorded. Results The mean operation time was 6.4 hours, mean instrumented vertebrae were 6.4 segments, and mean blood loss during operation was 364 mL. The coronal Cobb angles of the thoracic curve before and after surgery were 45.5 degrees and 15.4 degrees respectively, with an average correction rate of 65.4%. The lumbar curve was corrected from 28.4 degrees lation to 11.8 degrees, with an average simultaneous correction rate of 57.2%. All of the patients were followed up regularly with an average time of 21.4 months. At the final follow-up, the coronal Cobb angles of the thoracic and lumbar curves were 19.0 degrees and 20.1 degrees, with a 3.6 degrees and 8.3 degrees loss of correction, respectively. The apical vertebral translation was improved from 32.3 mm to 10.5 mm for the thoracic curve, and from 13.1 mm to 8.2 mm for the lumbar curve. There were 6 cases with peri-operative complications, including 1 case of thoracic effusion, 1 case of chylothorax, 1 case of locking plug loosing, 2 cases of aggravation of the unfused lumbar curve (1 case also with thoracolumbar kyphosis), and 1 case with a screw tip causing a contour deformity of the aorta. And 4 of them underwent revision surgery.

Conclusions: Video-assisted thoracoscopic anterior correction and fusion of scoliosis has good correction capability, less intraoperative bleeding, and favorable cosmetic effect for mild and moderate thoracic scoliosis, but with higher rates of correction loss of the lumbar curve and peri-operative complications. A surgeon should be cautious to perform this technique. ders

目的:探讨电视胸腔镜下脊柱侧凸前路矫正融合的手术方法及初步效果。方法:回顾我院2003年3月至2005年4月行胸腔镜前路矫正融合治疗脊柱侧凸11例的临床资料。他们都是女性,平均年龄为13.1岁。其中特发性侧凸9例,先天性侧凸1例,马凡氏综合征侧凸1例。测量术前、术后及最终随访时冠状Cobb角和椎体根尖位移。记录手术时间、术中出血量及围手术期并发症。结果平均手术时间6.4小时,平均固定椎体6.4节段,术中平均出血量364 mL。手术前后胸椎弯曲冠状Cobb角分别为45.5度和15.4度,平均矫正率65.4%。腰椎曲度由28.4度矫正至11.8度,平均同时矫正率为57.2%。所有患者均定期随访,平均随访时间为21.4个月。在最后随访时,胸椎和腰椎弯曲的Cobb冠状角分别为19.0度和20.1度,矫正损失分别为3.6度和8.3度。椎体顶端平移从32.3 mm提高到10.5 mm,从13.1 mm提高到8.2 mm。围手术期并发症6例,其中胸腔积液1例,乳糜胸1例,锁栓松动1例,腰椎弯曲未融合加重2例(合并胸腰椎后凸1例),螺钉尖端1例导致主动脉轮廓畸形。其中4人接受了翻修手术。结论:视频胸腔镜前路脊柱侧凸矫正融合治疗轻中度胸椎侧凸矫正能力好,术中出血少,美观效果好,但腰椎弯曲矫正丢失率及围术期并发症发生率较高。外科医生在使用这项技术时应小心谨慎。接单
{"title":"Video-assisted thoracoscopic correction and fusion of scoliosis.","authors":"Bin Yu,&nbsp;Jian-guo Zhang,&nbsp;Gui-xing Qiu,&nbsp;Yi-peng Wang,&nbsp;Xin-yu Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the operative technique and preliminary results of video-assisted thoracoscopic anterior correction and fusion of scoliosis.</p><p><strong>Methods: </strong>Eleven cases underwent thoracoscopic anterior correction and fusion of scoliosis from March 2003 to April 2005 in our hospital were reviewed. They were all females with an average age of 13.1 years old. Of which, 9 cases were idiopathic scoliosis, 1 case was congenital scoliosis, and 1 case was Marfan syndrome scoliosis. The coronal Cobb angle and apical vertebral translation before and after surgery as well as at final follow-up were measured. The operation time, blood loss during operation, and peri-operative complications were recorded. Results The mean operation time was 6.4 hours, mean instrumented vertebrae were 6.4 segments, and mean blood loss during operation was 364 mL. The coronal Cobb angles of the thoracic curve before and after surgery were 45.5 degrees and 15.4 degrees respectively, with an average correction rate of 65.4%. The lumbar curve was corrected from 28.4 degrees lation to 11.8 degrees, with an average simultaneous correction rate of 57.2%. All of the patients were followed up regularly with an average time of 21.4 months. At the final follow-up, the coronal Cobb angles of the thoracic and lumbar curves were 19.0 degrees and 20.1 degrees, with a 3.6 degrees and 8.3 degrees loss of correction, respectively. The apical vertebral translation was improved from 32.3 mm to 10.5 mm for the thoracic curve, and from 13.1 mm to 8.2 mm for the lumbar curve. There were 6 cases with peri-operative complications, including 1 case of thoracic effusion, 1 case of chylothorax, 1 case of locking plug loosing, 2 cases of aggravation of the unfused lumbar curve (1 case also with thoracolumbar kyphosis), and 1 case with a screw tip causing a contour deformity of the aorta. And 4 of them underwent revision surgery.</p><p><strong>Conclusions: </strong>Video-assisted thoracoscopic anterior correction and fusion of scoliosis has good correction capability, less intraoperative bleeding, and favorable cosmetic effect for mild and moderate thoracic scoliosis, but with higher rates of correction loss of the lumbar curve and peri-operative complications. A surgeon should be cautious to perform this technique. ders</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"144-51"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27074829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methylation pattern of LRP15 gene in leukemia. 白血病中LRP15基因的甲基化模式。
Li-ping Dou, Chang Wang, Zhou-min Xu, Hui-yuan Kang, Hui Fan, Fang-ding Lou, Li Yu

Objective: To investigate the methylation status of LRP15 gene in acute leukemia (AL) patients and its role in the tumorigenesis.

Methods: The methylation of LRP15 promoter and first exon of bone marrow mononuclear cells in 73 patients with AL, 10 with chronic leukemia (CL), 9 with hematological benign diseases, and 20 healthy transplantation donors was analyzed by using methylation specific polymerase chain reaction. The methylation of LRP15 gene promoter and first exon in COS7, K562, and HL60 cell lines was also assayed.

Results: No LRP15 gene promoter methylation was detected in COS7 cell line. LRP15 gene promoter was methylated in K562 and HL60 cell lines. No deletion of LRP15 gene was detected in all samples. In nearly all French-American-British leukemia subtypes, we found that frequency of LRP15 methylation in adult patients with AL was 71.23% (52/73). There was no detectable methylation in any of the 20 healthy donors and 8 chronic myeloid leukemia patients. The difference in frequency of LRP15 methylation between AL patients and healthy donors or CL patients (10.00%, 1/10) was significant (P < 0.01). Hypermethylation of LRP15 gene was found in 57.14% (16/28) of newly diagnosed AL patients, 83.33% of relapsed AL patients respectively, which was significantly different (P < 0.05). We also demonstrated LRP15 methylation in 55.56% (5/9) adults with benign hematological diseases.

Conclusions: LRP15 methylation changes are common abnormalities in leukemia. LRP15 is postulated to be a tumor suppressor gene.

目的:探讨LRP15基因在急性白血病(AL)患者中的甲基化状态及其在肿瘤发生中的作用。方法:应用甲基化特异性聚合酶链反应对73例AL患者、10例慢性白血病患者、9例血液学良性疾病患者和20例健康移植供者骨髓单个核细胞LRP15启动子和第一外显子的甲基化进行分析。在COS7、K562和HL60细胞系中也检测了LRP15基因启动子和第一外显子的甲基化。结果:COS7细胞株未检测到LRP15基因启动子甲基化。LRP15基因启动子在K562和HL60细胞系中甲基化。所有样本均未检测到LRP15基因缺失。在几乎所有法、美、英白血病亚型中,我们发现成年AL患者LRP15甲基化的频率为71.23%(52/73)。在20名健康供体和8名慢性髓性白血病患者中没有检测到甲基化。AL患者与健康供者或CL患者LRP15甲基化频率(10.00%,1/10)差异有统计学意义(P < 0.01)。LRP15基因高甲基化在新发AL患者中占57.14%(16/28),在复发AL患者中占83.33%,差异有统计学意义(P < 0.05)。我们还发现LRP15甲基化在55.56%(5/9)的良性血液病成人中发生。结论:LRP15甲基化改变是白血病中常见的异常。LRP15被认为是一种肿瘤抑制基因。
{"title":"Methylation pattern of LRP15 gene in leukemia.","authors":"Li-ping Dou,&nbsp;Chang Wang,&nbsp;Zhou-min Xu,&nbsp;Hui-yuan Kang,&nbsp;Hui Fan,&nbsp;Fang-ding Lou,&nbsp;Li Yu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the methylation status of LRP15 gene in acute leukemia (AL) patients and its role in the tumorigenesis.</p><p><strong>Methods: </strong>The methylation of LRP15 promoter and first exon of bone marrow mononuclear cells in 73 patients with AL, 10 with chronic leukemia (CL), 9 with hematological benign diseases, and 20 healthy transplantation donors was analyzed by using methylation specific polymerase chain reaction. The methylation of LRP15 gene promoter and first exon in COS7, K562, and HL60 cell lines was also assayed.</p><p><strong>Results: </strong>No LRP15 gene promoter methylation was detected in COS7 cell line. LRP15 gene promoter was methylated in K562 and HL60 cell lines. No deletion of LRP15 gene was detected in all samples. In nearly all French-American-British leukemia subtypes, we found that frequency of LRP15 methylation in adult patients with AL was 71.23% (52/73). There was no detectable methylation in any of the 20 healthy donors and 8 chronic myeloid leukemia patients. The difference in frequency of LRP15 methylation between AL patients and healthy donors or CL patients (10.00%, 1/10) was significant (P < 0.01). Hypermethylation of LRP15 gene was found in 57.14% (16/28) of newly diagnosed AL patients, 83.33% of relapsed AL patients respectively, which was significantly different (P < 0.05). We also demonstrated LRP15 methylation in 55.56% (5/9) adults with benign hematological diseases.</p><p><strong>Conclusions: </strong>LRP15 methylation changes are common abnormalities in leukemia. LRP15 is postulated to be a tumor suppressor gene.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"187-91"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27071875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase II study of gemcitabine combined with platinum chemotherapy for recurrent epithelial ovarian cancer. 吉西他滨联合铂化疗治疗复发性上皮性卵巢癌的II期研究。
Peng Peng, Keng Shen, Jia-xin Yang, Ming Wu, Hui-fang Huang, Ling-ya Pan, Jing-he Lang

Objective: To evaluate the anti-tumor effect and toxicity of gemcitabine combined with platinum chemotherapy on recurrent epithelial ovarian cancer.

Methods: Phase II study of gemcitabine combined with platinum chemotherapy was carried out in 22 patients with recurrent epithelial ovarian cancer. Median age of patients was 50.5 years old. Seven patients were platinum-sensitive and 15 patients were platinum-resistant or -refractory. All patients received gemcitabine combined with carboplatin or oxaliplatin chemotherapy. Patients' response rate (RR) and toxicity of gemcitabine combined with platinum chemotherapy were evaluated.

Results: A total of 98 gemcitabine-based chemotherapy cycles were performed. Total RR was 36.4%, RR of platinum-sensitive patients was 4/7 and platinum-resistant and -refractory patients was 4/15. The estimated median survival time was 10.0 months (95% CI: 7.0-13.0) after initiation of gemcitabine combined with platinum chemotherapy. There was no significant difference in survival time between platinum-resistant/refractory group and platinum-sensitive group (P = 0.061). Side effects of gemcitabine combined with platinum chemotherapy were observed in 81.8% of patients. Grade II/III anemia (54.5%) and grade III/IV neutropenia (54.5%) were most common toxicities. Ten (45.5%) patients had to delay their chemotherapy cycles or reduce the dose of chemotherapeutic drugs because of the severe side effects. Fourteen (63.6%) patients received granulocyte colony-stimulating factor to relieve neutropenia, and 8 (36.4%) patients received component blood transfusion to treat anemia or thrombocytopenia. There was no treat-ment-associated death.

Conclusion: Gemcitabine combined with platinum chemotherapy appears to be an effective and well-tolerant treatment for recurrent epithelial ovarian cancer, including platinum-resistant or -refractory diseases.

目的:评价吉西他滨联合铂化疗治疗复发性上皮性卵巢癌的抗肿瘤效果及毒性。方法:对22例复发性上皮性卵巢癌患者进行吉西他滨联合铂化疗的II期研究。患者中位年龄为50.5岁。7例患者为铂敏感,15例患者为铂耐药或难治。所有患者均接受吉西他滨联合卡铂或奥沙利铂化疗。评价吉西他滨联合铂化疗患者的缓解率(RR)和毒性。结果:共进行了98个吉西他滨化疗周期。总RR为36.4%,铂敏感组RR为4/7,铂耐药和难治组RR为4/15。在吉西他滨联合铂化疗开始后,估计中位生存时间为10.0个月(95% CI: 7.0-13.0)。铂耐药/难治组与铂敏感组的生存时间差异无统计学意义(P = 0.061)。81.8%的患者观察到吉西他滨联合铂化疗的副作用。II/III级贫血(54.5%)和III/IV级中性粒细胞减少(54.5%)是最常见的毒性。10例(45.5%)患者因毒副作用严重,不得不推迟化疗周期或减少化疗药物剂量。14例(63.6%)患者接受粒细胞集落刺激因子治疗中性粒细胞减少症,8例(36.4%)患者接受成分输血治疗贫血或血小板减少症。无治疗相关死亡。结论:吉西他滨联合铂化疗对复发性上皮性卵巢癌(包括铂耐药或难治性疾病)是一种有效且耐受性良好的治疗方法。
{"title":"Phase II study of gemcitabine combined with platinum chemotherapy for recurrent epithelial ovarian cancer.","authors":"Peng Peng,&nbsp;Keng Shen,&nbsp;Jia-xin Yang,&nbsp;Ming Wu,&nbsp;Hui-fang Huang,&nbsp;Ling-ya Pan,&nbsp;Jing-he Lang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the anti-tumor effect and toxicity of gemcitabine combined with platinum chemotherapy on recurrent epithelial ovarian cancer.</p><p><strong>Methods: </strong>Phase II study of gemcitabine combined with platinum chemotherapy was carried out in 22 patients with recurrent epithelial ovarian cancer. Median age of patients was 50.5 years old. Seven patients were platinum-sensitive and 15 patients were platinum-resistant or -refractory. All patients received gemcitabine combined with carboplatin or oxaliplatin chemotherapy. Patients' response rate (RR) and toxicity of gemcitabine combined with platinum chemotherapy were evaluated.</p><p><strong>Results: </strong>A total of 98 gemcitabine-based chemotherapy cycles were performed. Total RR was 36.4%, RR of platinum-sensitive patients was 4/7 and platinum-resistant and -refractory patients was 4/15. The estimated median survival time was 10.0 months (95% CI: 7.0-13.0) after initiation of gemcitabine combined with platinum chemotherapy. There was no significant difference in survival time between platinum-resistant/refractory group and platinum-sensitive group (P = 0.061). Side effects of gemcitabine combined with platinum chemotherapy were observed in 81.8% of patients. Grade II/III anemia (54.5%) and grade III/IV neutropenia (54.5%) were most common toxicities. Ten (45.5%) patients had to delay their chemotherapy cycles or reduce the dose of chemotherapeutic drugs because of the severe side effects. Fourteen (63.6%) patients received granulocyte colony-stimulating factor to relieve neutropenia, and 8 (36.4%) patients received component blood transfusion to treat anemia or thrombocytopenia. There was no treat-ment-associated death.</p><p><strong>Conclusion: </strong>Gemcitabine combined with platinum chemotherapy appears to be an effective and well-tolerant treatment for recurrent epithelial ovarian cancer, including platinum-resistant or -refractory diseases.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"177-82"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27074835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protection of carbon monoxide inhalation on lipopolysaccharide-induced multiple organ injury in rats. 一氧化碳吸入对脂多糖所致大鼠多器官损伤的保护作用。
Shao-hua Liu, Xin-rong Xu, Ke Ma, Bing Xu

Objective: To observe the protection of carbon monoxide (CO) inhalation on lipopolysaccharide (LPS)-induced rat multiple organ injury.

Methods: Sprague-Dawley rats with multiple organ injury induced by 5 mg/kg LPS intravenous injection were exposed to room air or 2. 5 x 10(-4) (V/V) CO for 3 hours. The lung and intestine tissues of rats were harvested to measure the expression of heme oxygenase-1 (HO-1) with reverse transcription-polymerase chain reaction, the levels of pulmonary tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and intestinal platelet activator factor (PAF), intercellular adhesion molecule-1 (ICAM-1) with enzyme-linked immunosorbent assay, the content of maleic dialdehyde (MDA) and the activity of myeloperoxidase (MPO) with chemical method, the cell apoptosis rate with flow cytometry, and the pathological changes with light microscope.

Results: CO inhalation obviously up-regulated the expression of HO-1 in lung (5.43 +/- 0.92) and intestine (6.29 +/- 1.56) in LPS + CO group compared with (3.08 +/- 0.82) and (3.97 +/- 1.16) in LPS group (both P < 0.05). The levels of TNF-alpha, IL-6 in lung and PAF, ICAM-1 in intestine of LPS + CO group were 0.91 +/- 0.25, 0.64 +/- 0.05, 1.19 +/- 0.52, and 1.83 +/- 0.35 pg/mg, respectively, significantly lower than the corresponding values in LPS group (1.48 +/- 0.23, 1.16 +/- 0.26, 1.84 +/- 0.73, and 3.48 +/- 0.36 pg/mg, all P < 0.05). The levels of MDA, MPO, and cell apoptosis rate in lung and intestine of LPS + CO group were 1.02 +/- 0.23 nmol/mg, 1.74 +/- 0.17 nmol/mg, 7.18 +/- 1.62 U/mg, 6.30 +/- 0.97 U/mg, 1.60% +/- 0.34%, and 30. 56% +/- 6.33%, respectively, significantly lower than the corresponding values in LPS group (1.27 +/- 0.33 nmol/mg, 2.75 +/- 0.39 nmol/mg, 8.16 +/- 1.49 U/mg, 7.72 +/- 1.07 U/mg, 3.18% +/- 0.51%, and 41.52% +/- 3.36%, all P < 0.05). In addition, injury of lung and intestine induced by LPS was attenuated at presence of CO inhalation.

Conclusion: CO inhalation protects rat lung and intestine from LPS-induced injury via anti-oxidantion, anti-inflammation, anti-apoptosis, and up-regulation of HO-1 expression.

目的:观察一氧化碳(CO)吸入对脂多糖(LPS)所致大鼠多器官损伤的保护作用。方法:将静脉注射5 mg/kg LPS致多脏器损伤的sd - dawley大鼠分别暴露于室内空气或2。5 × 10(-4) (V/V) CO 3小时。取大鼠肺、肠组织,采用逆转录聚合酶链反应法检测血红素加氧酶-1 (HO-1)的表达,采用酶联免疫吸附法检测肺肿瘤坏死因子- α (tnf - α)、白细胞介素-6 (IL-6)、肠道血小板激活因子(PAF)、细胞间粘附分子-1 (ICAM-1)的水平,化学法检测丙二醛(MDA)含量和髓过氧化物酶(MPO)活性。流式细胞术观察细胞凋亡率,光镜观察病理变化。结果:CO吸入明显上调了HO-1在LPS + CO组肺(5.43 +/- 0.92)和肠道(6.29 +/- 1.56)的表达,而LPS组(3.08 +/- 0.82)和(3.97 +/- 1.16)(均P < 0.05)。LPS + CO组肺组织中tnf - α、IL-6水平和肠组织中PAF、ICAM-1水平分别为0.91 +/- 0.25、0.64 +/- 0.05、1.19 +/- 0.52、1.83 +/- 0.35 pg/mg,显著低于LPS组(1.48 +/- 0.23、1.16 +/- 0.26、1.84 +/- 0.73、3.48 +/- 0.36 pg/mg,均P < 0.05)。LPS + CO组大鼠肺、肠组织MDA、MPO水平分别为1.02 +/- 0.23 nmol/mg、1.74 +/- 0.17 nmol/mg、7.18 +/- 1.62 U/mg、6.30 +/- 0.97 U/mg、1.60% +/- 0.34%、30。分别为56% +/- 6.33%,显著低于LPS组(1.27 +/- 0.33 nmol/mg、2.75 +/- 0.39 nmol/mg、8.16 +/- 1.49 U/mg、7.72 +/- 1.07 U/mg、3.18% +/- 0.51%、41.52% +/- 3.36%,均P < 0.05)。此外,吸入一氧化碳可减轻LPS对肺和肠的损伤。结论:CO吸入可通过抗氧化、抗炎、抗凋亡、上调HO-1表达等机制保护lps诱导的大鼠肺、肠损伤。
{"title":"Protection of carbon monoxide inhalation on lipopolysaccharide-induced multiple organ injury in rats.","authors":"Shao-hua Liu,&nbsp;Xin-rong Xu,&nbsp;Ke Ma,&nbsp;Bing Xu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To observe the protection of carbon monoxide (CO) inhalation on lipopolysaccharide (LPS)-induced rat multiple organ injury.</p><p><strong>Methods: </strong>Sprague-Dawley rats with multiple organ injury induced by 5 mg/kg LPS intravenous injection were exposed to room air or 2. 5 x 10(-4) (V/V) CO for 3 hours. The lung and intestine tissues of rats were harvested to measure the expression of heme oxygenase-1 (HO-1) with reverse transcription-polymerase chain reaction, the levels of pulmonary tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and intestinal platelet activator factor (PAF), intercellular adhesion molecule-1 (ICAM-1) with enzyme-linked immunosorbent assay, the content of maleic dialdehyde (MDA) and the activity of myeloperoxidase (MPO) with chemical method, the cell apoptosis rate with flow cytometry, and the pathological changes with light microscope.</p><p><strong>Results: </strong>CO inhalation obviously up-regulated the expression of HO-1 in lung (5.43 +/- 0.92) and intestine (6.29 +/- 1.56) in LPS + CO group compared with (3.08 +/- 0.82) and (3.97 +/- 1.16) in LPS group (both P < 0.05). The levels of TNF-alpha, IL-6 in lung and PAF, ICAM-1 in intestine of LPS + CO group were 0.91 +/- 0.25, 0.64 +/- 0.05, 1.19 +/- 0.52, and 1.83 +/- 0.35 pg/mg, respectively, significantly lower than the corresponding values in LPS group (1.48 +/- 0.23, 1.16 +/- 0.26, 1.84 +/- 0.73, and 3.48 +/- 0.36 pg/mg, all P < 0.05). The levels of MDA, MPO, and cell apoptosis rate in lung and intestine of LPS + CO group were 1.02 +/- 0.23 nmol/mg, 1.74 +/- 0.17 nmol/mg, 7.18 +/- 1.62 U/mg, 6.30 +/- 0.97 U/mg, 1.60% +/- 0.34%, and 30. 56% +/- 6.33%, respectively, significantly lower than the corresponding values in LPS group (1.27 +/- 0.33 nmol/mg, 2.75 +/- 0.39 nmol/mg, 8.16 +/- 1.49 U/mg, 7.72 +/- 1.07 U/mg, 3.18% +/- 0.51%, and 41.52% +/- 3.36%, all P < 0.05). In addition, injury of lung and intestine induced by LPS was attenuated at presence of CO inhalation.</p><p><strong>Conclusion: </strong>CO inhalation protects rat lung and intestine from LPS-induced injury via anti-oxidantion, anti-inflammation, anti-apoptosis, and up-regulation of HO-1 expression.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"169-76"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27074834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of glibenclamide, glimepiride, and gliclazide on ischemic preconditioning in rat heart. 格列本脲、格列美脲和格列齐特对大鼠心脏缺血预处理的影响。
Guo-ting Wu, Lin Wang, Jun Li, Wei-zhong Zhu

Objective: To compare the influence of different sulfonylureas on the myocardial protection effect of ischemic preconditioning (IPC) in isolated rat hearts, and ATP-sensitive potassium channel current (IK(ATP)) of rat ventricular myocytes.

Methods: Isolated Langendorff perfused rat hearts were randomly assigned to five groups: (1) control group, (2) IPC group, (3) IPC + glibenclamide (GLB, 10 micromol/L) group, (4) IPC + glimepiride (GLM, 10 micromol/L) group, (5) IPC + gliclazide (GLC, 50 micromol/L) group. IPC was defined as 3 cycles of 5-minute zero-flow global ischemia followed by 5-minute reperfusion. The haemodynamic parameters and the infarct size of each isolated heart were recorded. And the sarcolemmal IK(ATP) of dissociated ventricular myocytes reperfused with 10 micromol/L GLB, 1 micromol/L GLM, and 1 micromol/L GLC was recorded with single-pipette whole-cell voltage clamp under simulated ischemic condition.

Results: The infarct sizes of rat hearts in IPC (23.7% +/- 1.3%), IPC + GLM (24.6% +/- 1.0%), and IPC + GLC (33.1% +/- 1.3%) groups were all significantly smaller than that in control group (43.3% +/- 1.8%; P < 0.01, n = 6). The infarct size of rat hearts in IPC + GLB group (40.4% +/- 1.4%) was significantly larger than that in IPC group (P < 0.01, n=6). Under simulated ischemic condition, GLB (10 micromol/L) decreased IK(ATP) from 20.65 +/- 7.80 to 9.09 +/- 0.10 pA/pF (P < 0.01, n=6), GLM (1 micromol/L) did not significantly inhibit IK(ATP) (n=6), and GLC (1 micromol/L) decreased IK(ATP) from 16.73 +/- 0.97 to 11. 18 +/- 3.56 pA/pF (P < 0.05, n=6).

Conclusions: GLM has less effect on myocardial protection of IPC than GLB and GLC. Blockage of sarcolemmal ATP-sensitive potassium channels in myocardium might play an important role in diminishing IPC-induced protection of GLM, GLB, and GLC.

目的:比较不同磺脲类药物对离体大鼠心脏缺血预处理(IPC)心肌保护作用及大鼠心室肌细胞ATP敏感钾通道电流(IK(ATP))的影响。方法:将离体Langendorff灌注大鼠心脏随机分为5组:(1)对照组,(2)IPC组,(3)IPC +格列本脲(GLB, 10微mol/L)组,(4)IPC +格列美脲(GLM, 10微mol/L)组,(5)IPC +格列齐特(GLC, 50微mol/L)组。IPC定义为3个周期,5分钟零流量全脑缺血,然后5分钟再灌注。记录离体心脏血流动力学参数及梗死面积。在模拟缺血条件下,用单吸管全细胞电压钳记录10微mol/L GLB、1微mol/L GLM、1微mol/L GLC再灌注解离心室肌细胞的肌上皮IK(ATP)。结果:IPC组(23.7% +/- 1.3%)、IPC + GLM组(24.6% +/- 1.0%)、IPC + GLC组(33.1% +/- 1.3%)大鼠心肌梗死面积均显著小于对照组(43.3% +/- 1.8%);IPC + GLB组大鼠心肌梗死面积(40.4% +/- 1.4%)显著大于IPC组(P < 0.01, n=6)。在模拟缺血状态下,GLB(10微mol/L)使IK(ATP)从20.65 +/- 7.80降低到9.09 +/- 0.10 pA/pF (P < 0.01, n=6), GLM(1微mol/L)对IK(ATP)无显著抑制作用(n=6), GLC(1微mol/L)使IK(ATP)从16.73 +/- 0.97降低到11。18±3.56 pA/pF (P < 0.05, n=6)。结论:GLM对IPC的心肌保护作用低于GLB和GLC。阻断心肌肌层atp敏感钾通道可能在削弱ipc诱导的GLM、GLB和GLC的保护作用中起重要作用。
{"title":"Effects of glibenclamide, glimepiride, and gliclazide on ischemic preconditioning in rat heart.","authors":"Guo-ting Wu,&nbsp;Lin Wang,&nbsp;Jun Li,&nbsp;Wei-zhong Zhu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To compare the influence of different sulfonylureas on the myocardial protection effect of ischemic preconditioning (IPC) in isolated rat hearts, and ATP-sensitive potassium channel current (IK(ATP)) of rat ventricular myocytes.</p><p><strong>Methods: </strong>Isolated Langendorff perfused rat hearts were randomly assigned to five groups: (1) control group, (2) IPC group, (3) IPC + glibenclamide (GLB, 10 micromol/L) group, (4) IPC + glimepiride (GLM, 10 micromol/L) group, (5) IPC + gliclazide (GLC, 50 micromol/L) group. IPC was defined as 3 cycles of 5-minute zero-flow global ischemia followed by 5-minute reperfusion. The haemodynamic parameters and the infarct size of each isolated heart were recorded. And the sarcolemmal IK(ATP) of dissociated ventricular myocytes reperfused with 10 micromol/L GLB, 1 micromol/L GLM, and 1 micromol/L GLC was recorded with single-pipette whole-cell voltage clamp under simulated ischemic condition.</p><p><strong>Results: </strong>The infarct sizes of rat hearts in IPC (23.7% +/- 1.3%), IPC + GLM (24.6% +/- 1.0%), and IPC + GLC (33.1% +/- 1.3%) groups were all significantly smaller than that in control group (43.3% +/- 1.8%; P < 0.01, n = 6). The infarct size of rat hearts in IPC + GLB group (40.4% +/- 1.4%) was significantly larger than that in IPC group (P < 0.01, n=6). Under simulated ischemic condition, GLB (10 micromol/L) decreased IK(ATP) from 20.65 +/- 7.80 to 9.09 +/- 0.10 pA/pF (P < 0.01, n=6), GLM (1 micromol/L) did not significantly inhibit IK(ATP) (n=6), and GLC (1 micromol/L) decreased IK(ATP) from 16.73 +/- 0.97 to 11. 18 +/- 3.56 pA/pF (P < 0.05, n=6).</p><p><strong>Conclusions: </strong>GLM has less effect on myocardial protection of IPC than GLB and GLC. Blockage of sarcolemmal ATP-sensitive potassium channels in myocardium might play an important role in diminishing IPC-induced protection of GLM, GLB, and GLC.</p>","PeriodicalId":10186,"journal":{"name":"Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih","volume":"22 3","pages":"162-8"},"PeriodicalIF":0.0,"publicationDate":"2007-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"27074833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1